544529 — Aptus Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹615.96m
- IN₹719.53m
- IN₹245.58m
Annual cashflow statement for Aptus Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | IAS | IAS | IAS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | 2.95 | 11.2 | 42 |
| Depreciation | |||
| Non-Cash Items | 0 | -0.253 | -0.771 |
| Other Non-Cash Items | |||
| Changes in Working Capital | -6.57 | -34.8 | -62.2 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Other Assets | |||
| Change in Accounts Payable | |||
| Change in Other Liabilities | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | -1.81 | -21.7 | -18.4 |
| Capital Expenditures | -3.53 | -3.3 | -6.22 |
| Purchase of Fixed Assets | |||
| Other Investing Cash Flow Items | — | 0.252 | 0.77 |
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -3.53 | -3.04 | -5.45 |
| Financing Cash Flow Items | -1.43 | -2.39 | 9.34 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 8.1 | 28.6 | 66.8 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 2.76 | 3.78 | 43 |